To better connect patients and researchers, three pharmaceutical companies are partnering with clinicaltrials.gov on a new platform to improve access to information about clinical trials.
More than half of Americans say they would be interested in participating in a clinical trial but almost half of all studies never reach their recruitment targets.
To address the problem, Novartis, Pfizer and Eli Lilly are collaborating on a platform that will enhance clinicaltrials.gov and provide more detailed and patient-friendly information about trials, including a machine readable “target health profile” to improve the ability of healthcare software to match individual health profiles to applicable clinical trials.
Additionally, patients can search for trials themselves using their own Blue Button data.
The platform launch is planned for early 2014 with a starting database of about 50 clinical research studies from the participating companies. The platform will be open on both ends allowing other sponsors of clinical research studies to upload information about their trials, while software companies develop tools to deliver information to interested patients.